Bioperfectus Real-Time PCR Systems Included in FDA-listed for IVD Testing

Company news


April 17, Shanghai—Today, we Bioperfectus are proud to announce that STC-96A and STC-96A PLUS Real-Time PCR Systems have been listed with the U.S. Food and Drug Administration (FDA) for IVD testing. With FDA registration, Bioperfectus Real-Time PCR Systems obtained access to PCR laboratories in the US. With stable performance and user-friendly design, STC-96A and STC-96A Plus will be great helpers for molecular laboratories to identify the virus and bacterial.


Throughout the COVID-19 pandemic, Bioperfecuts Real-Time PCR Systems with CE Mark have been distributed to over 100 PCR laboratories, molecular diagnostic centers, hospitals, and national laboratories worldwide since the product’s launch last November.



Besides STC-96A and STC-96A PLUS PCR system, our automated nucleic acid extraction workstation SAW-96, nucleic acid extraction system (SSNP-2000B/3000A/9600A, SMPE-960), and all extraction kits are also included in FDA-Listed for IVD Testing.



Source: US Food & Drug Administration,


Bioperfecuts One Solution, One Supplier, One Response (3 “Ones”)Total PCR Solution was introduced earlier this year with a strategy to provide the most advanced molecular diagnostic solution to laboratories worldwide with the fastest and most professional response.


For now Bioperfecuts could provide products from nucleic acids extraction to PCR, from instruments to reagents as a Total PCR Solution supplier for U.S. laboratories.


About Bioperfectus


Bioperfectus, a publicly listed company on Shanghai Stock Exchange (SSE:688399), has been a leading molecular diagnostic solution provider specializing in infectious diseases since 2010. With headquarters in Jiangsu, and subsidiaries in Shanghai, Beijing, Xi'an, Taizhou, Hainan, and Yinchuan. Bioperfectus is pioneering in the molecular diagnostics market with our products ranging from real-time PCR kits, nucleic acid extraction systems, rapid tests, and automation laboratory devices. Young and passionate, Bioperfectus people are working steadily and firmly to achieve our dream of creating a healthier future for our next generations. For more information, please follow us on LinkedIn or visit .


Bioperfectus Monkeypox Virus PCR Kit to Support Testing Across Africa

Mr. TUNC MERT SAYIN addressed the opening ceremony of the Training Workshop on Monkeypox Diagnosis Using Real Time PCR Technique held by Africa Centers for Disease Control and Prevention in collaboration with Nigeria Center for Disease Control (Nigeria CDC) and Africa Society for Laboratory Medicine (ASLM).


Next pandemic? Concerns growing as monkeypox virus cases surge

On 17 June, the WHO released its latest update on the Monkeypox outbreak situation. The sharp growth of confirmed cases during the last two months indicates increasing uncertainty of the endemic progress. Between 1 January and 15 June 2022, a cumulative total of 2103 laboratory confirmed cases, one probable case, and one death were laboratory-confirmed had reported to WHO from 42 countries in five WHO Regions. The majority of cases (98%) have been reported since May 2022. Most cases are recognized and reported from European countries, followed by the American region.


Let Love Continue: World Blood Donor Day 2022

Countries worldwide celebrate World Blood Donor Day (WBDD) every year. The event serves to raise awareness of the need for safe blood and blood products and to thank voluntary, unpaid blood donors for their life-saving gifts of blood.